Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 37767853
Corrigendum to Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
Journal of diabetes investigation
2023
PMID: 37767853
View on PubMed
DOI: 10.1111/jdi.14080
Semaglutide
Corrigendum to Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial. | Pepdox